Expensify Stock Forum

Gainers:
In reaction to earnings/guidance:
• $Payoneer Global(PAYO.US)$ +19.4%, $Toast(TOST.US)$ +13.1%, $PDF Solutions(PDFS.US)$ +7.7%, $Wheels Up Experience(UP.US)$ +7.1%, $LegalZoom(LZ.US)$ +6.5%, $Joby Aviation(JOBY.US)$ +3.6%, $indie Semiconductor(INDI.US)$ +2.9%, $Rocket Lab(RKLB.US)$ +2.4%, $Rivian Automotive(RIVN.US)$ +1.2%
Other news:
• $WeTrade Group(WETG.US)$ +47.8%(announces $50 million sales of monkeypox virus test kits to Par...

Upgrades
• $BorgWarner(BWA.US)$ : Deutsche Bank Upgrades to Buy from Hold - PT $48 (from $43)
• $Expensify(EXFY.US)$ : BofA Securities Upgrades to Buy from Neutral - PT $25 (from $20)
• $Grab Holdings(GRAB.US)$ : JPMorgan Upgrades to Overweight from Neutral - PT $3
• $Houlihan Lokey(HLI.US)$ : Morgan Stanley Upgrades to Equalweight from Underweight - PT $82 (from $95)
• $JPMorgan(JPM.US)$ : Berenberg Upgrades to Hold from Sell - PT ...

$Torm(TRMD.US)$
  - Stock breaking out and moving higher. Looking to add above $13
$Expensify(EXFY.US)$
- stock breaking out after it reported earnings recently. Co announced a 50M buyback. Adding above $21.5
$JE Cleantech Holdings Limited(JCSE.US)$
- Recent IPO. moving higher after hitting bottom. Stocking having multiple green day recently. Watching next key resistance at $14.50
$H&R Block(HRB.US)$
  - Stock breaking out on the recent earnings report. Needs to br...

Upgrades
• $Advanced Micro Devices(AMD.US)$ : Raymond James Upgrades to Strong Buy from Outperform - PT $160
• $AutoNation(AN.US)$ : Truist Securities Upgrades to Buy from Hold - PT $140 (from $130)
• $BioLife Solutions(BLFS.US)$ : Oppenheimer Upgrades to Outperform from Perform - PT $28
• $Biomarin Pharmaceutical(BMRN.US)$ : Morgan Stanley Upgrades to Overweight from Equalweight - PT $113 (from $96)
• $GoDaddy(GDDY.US)$ : Piper Sandler Upgrades to Overweight ...

Gainers:
• $Clovis Oncology(CLVS.US)$ +40.6% (Rubraca significantly improves progression-free survival in first-line maintenance treatment in women with ovarian cancer regardless of their biomarker status in phase 3 athena-mono trial)
• $Dare Bioscience(DARE.US)$ +13.61% (Organon and Dar Bioscience have entered into an agreement whereby Organon will license global rights to XACIATO)
• $KULR Technology(KULR.US)$ +9.5% (secured a battery sa...